Mr Kit Wong

Consultant Cardiothoracic Surgeon


Personal profile

"Despite the large number of complex interventions he performs, patients tell us he is relaxed and caring - equally reassuring is his zero per cent mortality rate for first-time aortic-valve replacement over the past three years".

Kit Wong is an eminent heart surgeon in London with surgical expertise in mitral valve, coronary artery, aortic valve, aortic aneurysm and minimally invasive aortic procedures. Kit qualified from St Mary’s Hospital Medical School in 1986 and is currently a Consultant and was previously the Clinical Director of Cardiothoracic Surgery at Barts Health.

His formative cardiothoracic training was at the prestigious and world renown Royal Brompton and London Chest Hospitals where pioneering heart surgery was first performed. At the Royal Brompton Hospital, he trained closely with Professor Sir Magdi Yacoub who has had a major influence in his career developing his interests in aortic aneurysm and valvular heart surgery. Kit spent a further year with Sir Magdi producing the seminal and landmark research on the modulation of cardiac muscles which spawned major research in the UK and internationally, and its use in clinical treatment (Harefield protocol).

He is a Fellow of the Royal College of Surgeons of England, Society of Cardiothoracic Surgeons of Great Britain & Ireland, and has served on the council of the Royal Society of Medicine and the International College of Surgeons. He has also served as a specialist adviser on the panel of the London Cardiovascular Project, a group commissioned by NHS London to improve the model of care for cardiac surgery.

Kit has one of the best cardiac surgical results in the country with rates of survival significantly better than that predicted as evidenced by cardiac surgical results which have been published nationally since 2005. In the most recent National Adult Cardiac Surgery Audit produced for 2008-11, his results are outstanding with survival for all cardiac surgery 97.4%. He has a 100% and 98.4% survival for aortic valve and coronary artery bypass surgery, respectively, within this period.

Year qualified: